Traffic Lights - Latest Updates

Last updated: 05/09/2022

Other updates on this site
Drug Name Classification Clinical Indication Comments
Abaloparatide (NEW) Red Treating osteoporosis after menopause

TA991

BETULA VERRUCOSA ALLERGEN EXTRACT (Itulazax®) Orange Moderate to severe allergic rhinitis/conjunctivitis caused by Birch pollen

SCA Link Adult

 

DOXYLAMINE SUCCINATE AND PYRIDOXINE (Xonvea®) Do not prescribe Nausea and vomiting in pregnancy
Indium 111 Oxinate (NEW) Red radiopharmaceutical for platelet and leukocyte studies
Latanoprost–netarsudil eye drops (NEW) Green Primary open-angle glaucoma or ocular hypertension

TA1009

NICARDIPINE injection (NEW) Red Blood pressure reduction in acute intra-cerebral haemorrhage within 6 hours of onset

Second line agent

Relugolix (NEW) Red For treating hormone sensitive prostate cancer

TA995

SYSTANE® ULTRA preservative free eye drops (UPDATED) Yellow Ocular lubricant

Evaporative Dry Eye & Meibomian Gland Dysfunction only

*Thealipid preservative free eye drops are first choice across LLR

TADALAFIL (10mg and 20mg) Green Erectile dysfunction

For patients who have not responded to sildenafil or to vardenafil. 10mg and 20mg for PRN dosing.

NHS limitations on groups and frequency of prescribing apply. FP10 prescriptions should be endorsed with “SLS“.

TADALAFIL 5mg Green Erectile dysfunction

Approved for daily administration for individuals requiring more than 4 doses per month.

Do not prescribe 2.5mg OD dosing.

NHS limitations on groups and frequency of prescribing apply. Fp10 prescriptions must be endorsed with “SLS”.

TheaLipid eye drops (NEW) Yellow Evaporative Dry Eye & Meibomian Gland Dysfunction

First line for evaporative dry eye & meibomian gland dysfunction only

Varenicline Tartrate Grey Smoking cessation in adults
Vibegron (NEW) Green Overactive bladder syndrome in adults

Other Updates on this Website

Recent documents from LLR APC and TAS


About the Leicester, Leicestershire and Rutland Area Prescribing Committee

In common with other local health communities, the Leicester, Leicestershire and Rutland Area Prescribing Committee (LLR APC) acknowledges the benefits of having a Leicestershire Health Community-wide strategy for the prescribing of specialist medicines and the managed entry of new drugs and related technologies.

Leicestershire Health Community comprises the Leicester, Leicestershire and Rutland Integrated Care Board, University Hospitals of Leicester (UHL) NHS Trust and Leicestershire Partnership NHS Trust (LPT), amongst which there is a total consensus on the need for this strategy, and the LLR APC has been in place since 2005. Learn more